International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Top Cited Papers
Open Access
- 23 December 2015
- journal article
- perspective
- Published by Elsevier BV in Cytotherapy
- Vol. 18 (2), 151-159
- https://doi.org/10.1016/j.jcyt.2015.11.008
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implicationsNature Immunology, 2014
- Bone marrow-derived mesenchymal stromal cells improve vascular regeneration and reduce leukocyte-endothelium activation in critical ischemic murine skin in a dose-dependent mannerCytotherapy, 2014
- Low Intensity Pulsed Ultrasound Enhanced Mesenchymal Stem Cell Recruitment through Stromal Derived Factor-1 Signaling in Fracture HealingPLOS ONE, 2014
- The Role of CCL5 in the Ability of Adipose Tissue-Derived Mesenchymal Stem Cells to Support Repair of Ischemic RegionsStem Cells and Development, 2014
- Concise review: Combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapyThe International Journal of Cell Cloning, 2013
- MSCs: science and trialsNature Medicine, 2013
- Mesenchymal Stromal Cells Improve Survival During Sepsis in the Absence of Heme Oxygenase-1: The Importance of NeutrophilsThe International Journal of Cell Cloning, 2013
- Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage DifferentiationMolecular Therapy, 2012
- Down-Regulation of MHC II in Mesenchymal Stem Cells at High IFN-γ Can Be Partly Explained by Cytoplasmic Retention of CIITAPublished by The American Association of Immunologists ,2008
- Monocyte Chemotactic Protein-3 Is a Myocardial Mesenchymal Stem Cell Homing FactorThe International Journal of Cell Cloning, 2006